The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
Subscribe To Our Newsletter & Stay Updated
